It’s the last day to subscribe to MapmyIndia’s IPO, which is oversubscribed by six times

• MapmyIndia’s IPO has been subscribed 6.16 times in the first two days of its issue.
• The price band for the public issue has been fixed at ₹1,000-1,033.
• The portion reserved for retail investors has been subscribed 7.17 times.

The initial public offering (IPO) of CE Info Systems — the parent company of MapmyIndia — has been subscribed 6.16 times in the first two days of its issue. The issue will open for subscription for the last time today, December 13.

The price band for the public issue has been fixed at ₹1,000-1,033. The lot size will be of 14 equity shares and in multiples of 14 shares thereafter.

The portion reserved for retail investors has been subscribed 7.17 times, whereas the portion for non-institutional investors has been subscribed 6.27 times.

The grey market premium (GMP) of the company’s shares was at ₹900 on December 10.

MapmyIndia was founded in 1995 by Rakesh and Rashmi Verma. The company is currently being led by Rohan Verma. The company builds digital map data, telematics services, location-based software-as-a-services (SaaS) and geographic information system (GIS) services.

The company intends to raise ₹1,040 crore IPO entirely through an offer for sale (OfS), which will give partial exits to MapmyIndia’s cofounder Rashmi Verma, Qualcomm Asia Pacific, Zenrin and others. The digital maps company is looking to sell 1,00,63,945 equity shares.

MapMyIndia reported a revenue of ₹152 crore from its operation in fiscal year 2021 and its net profit was around ₹59 crore. In the first half of FY2022 — between April to September 2021 — the company’s revenue was at ₹100 crore and net profit was at ₹46 crore.

MapMyIndia reported a revenue of ₹152 crore from its operation in fiscal year 2021 and its net profit was around ₹59 crore. In the first half of FY2022 — between April to September 2021 — the company’s revenue was at ₹100 crore and net profit was at ₹46 crore.

SEE ALSO
MapmyIndia’s grey market premium is at ₹900 — here’s all you need to know about the business

Rakesh Jhunjhunwala-backed Star Health lists at a discount of nearly 6%

Metro Brands is aggressively planning on opening new stores despite COVID-19’s impact on its profits